Skip to content
Screener

GoodRx Holdings, Inc. GDRX Operating Cash Flow

Operating Cash Flow at other companies

CVS Health logo
CVS HealthCVS
$6.35B+234%
Amazon logo
AmazonAMZN
$45.39B+39.6%
OptimizeRx logo
OptimizeRxOPRX
-$467K-112%
Doximity logo
DoximityDOCS
$41.99M-32.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$21.24M-125%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$122.94M+21.0%

Other financials

Income statement

See full
Revenue$200.4M-1.3%
Gross profit$179.4M-5.4%
Operating income$23.6M-11.9%
Net income$8.5M-33.5%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$296.1M+5.3%
Total debt$539.0M-1.6%
Total equity$647.6M+0.7%
Total assets$2.3B+77.7%

Cash flow

See full
CapEx$362.0K-7.2%
Free cash flow$80.5M+63.6%

Valuation

See full
Market cap$1.27B-18.1%
Enterprise value$1.51B-16.8%
P/E78.1×+33.3×
P/S1.6×-0.3×

Profitability

See full
Gross margin90.8%-2.8pp
Operating margin9.5%-1.6pp
Net margin2.1%-2.3pp
FCF margin25.1%+1.4pp

Returns & leverage

See full
Return on equity2.5%-2.8pp
Debt / equity0.8×0.0×
Current ratio1.4×-2.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001809519-26-000152
(in thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Accrued expenses and other current liabilities (1)16,0635,585
Operating lease liabilities(2,912)(3,187)
Other liabilities125294
Net cash provided by operating activities92,67058,993
Cash flows from investing activities
Purchase of property and equipment(1,498)(532)
Acquisition(30,000)
Capitalized software(34,555)(39,659)

Item 1. Financial Statements

FAQ

What is GoodRx Holdings, Inc.'s operating cash flow?
GoodRx Holdings, Inc. (GDRX) reported operating cash flow of $80.83M in Q2 2026.
How has GoodRx Holdings, Inc.'s operating cash flow changed year-over-year?
GoodRx Holdings, Inc.'s operating cash flow increased by 63.0% year-over-year, from $49.58M to $80.83M.
What is the long-term trend for GoodRx Holdings, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s operating cash flow has grown at a -1.6% compound annual growth rate (CAGR), from $178.78M to $167.9M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about GoodRx Holdings, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude